SmallCapIntel Stock Signal

$BDRX

BDRX

Live signal history, momentum scoring, market alert activity, and recent catalysts.

Latest Signal

Active Watch

Grade

Grade C

Score

60/100

Speculative Confidence

Change

+82.49%

Previous Volume

202K

Signal Strength

Speculative Watch

60%

LowSpeculativeHighExtreme

Intelligence Summary

Why this signal matters

BDRX triggered a C-rated Active Watch after moving +82.49%. The stock is currently priced at $1.30, with prior-session volume of 202K. SmallCapIntel assigned a 60/100 score based on price momentum, liquidity quality, and trader-friendly price-zone behavior.

Signal Breakdown

Score Components

Momentum32/35
Liquidity4/25
Price Quality20/20
Bonus4/10
Penalties0
Total60/100

Recent Catalysts

News and market-moving context

10 items found

ADR Ratio Change

GlobeNewswire Inc. · 3/18/2026, 9:00:00 PM

No Clear CatalystUnknown Strength

Biodexa Pharmaceuticals announced a 1-for-5 reverse ADR split, effective April 6, 2026, to bring its ADR price into compliance with Nasdaq's $1.00 minimum bid price requirement. The ratio change will convert every 5 old ADRs into 1 new ADR, with fractional shares sold and proceeds distributed to holders.

BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm

GlobeNewswire Inc. · 10/29/2024, 8:00:00 PM

FDA / ClinicalHigh Strength

Biodexa Pharmaceuticals Plc reported updated data on a Phase 1 study of its drug MX110 in the treatment of recurrent glioblastoma, with two out of four patients in the study now deceased.

BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm

GlobeNewswire Inc. · 10/23/2024, 8:00:00 PM

FDA / ClinicalHigh Strength

Biodexa Pharmaceuticals Plc reported updated data on a Phase 1 study of its drug MX110 in the treatment of recurrent glioblastoma, with two out of four patients in the study now deceased.

Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Benzinga · 7/12/2024, 9:35:41 AM

Earnings / FinancialsMedium Strength

Ericsson reported better-than-expected Q2 sales and issued guidance, causing its shares to rise in pre-market trading. Several other stocks also saw significant pre-market movement, both positive and negative.

Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Benzinga

Benzinga · 7/11/2024, 6:02:49 PM

Earnings / FinancialsMedium Strength

ConAgra Brands reported weaker-than-expected Q4 sales and issued FY25 EPS guidance below estimates, causing its shares to decline. Other notable movers include Kazia Therapeutics, Biodexa Pharmaceuticals, and Volcon, which saw significant gains, while Delta Air Lines, American Airlines, and United Airlines declined.

Bull Case

Why traders may watch it

✓ Strong price momentum relative to the current market session.
✓ Price sits in a trader-friendly range where small-cap momentum can attract attention.
✓ Momentum and liquidity conditions are aligned enough to earn a bonus score.

Risk Factors

What could go wrong

⚠ Small-cap momentum can reverse quickly.
⚠ High percentage moves often come with elevated volatility.
⚠ Liquidity score is limited, which may increase spread and execution risk.
⚠ This is not investment advice and should be used for research only.

Signal History

2 total alerts logged for $BDRX.

View all alerts →

Active Watch

9/13/2026, 1:38:53 PM

Grade: CScore: 60/100+82.49%$1.30Prev Vol: 202K

Active Watch

9/12/2026, 1:38:54 PM

Grade: CScore: 60/100+82.49%$1.30Prev Vol: 202K

Market data is informational only. Not investment advice.